(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 4.92% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.84%.
Revvity's revenue in 2025 is $2,769,868,000.On average, 6 Wall Street analysts forecast RVTY's revenue for 2025 to be $335,967,545,857, with the lowest RVTY revenue forecast at $333,242,281,449, and the highest RVTY revenue forecast at $339,087,437,888. On average, 6 Wall Street analysts forecast RVTY's revenue for 2026 to be $357,805,139,896, with the lowest RVTY revenue forecast at $352,607,087,890, and the highest RVTY revenue forecast at $362,524,641,082.
In 2027, RVTY is forecast to generate $385,313,089,668 in revenue, with the lowest revenue forecast at $383,473,615,754 and the highest revenue forecast at $387,287,877,952.